{"id":129346,"date":"2013-05-12T03:05:47","date_gmt":"2013-05-12T07:05:47","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/the-klein-donation-text-of-robert-kleins-response-re-stemcells-inc\/"},"modified":"2024-08-17T20:31:04","modified_gmt":"2024-08-18T00:31:04","slug":"the-klein-donation-text-of-robert-kleins-response-re-stemcells-inc-3","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/the-klein-donation-text-of-robert-kleins-response-re-stemcells-inc-3.php","title":{"rendered":"The Klein Donation: Text of Robert Klein’s Response re StemCells, Inc."},"content":{"rendered":"

Here is the text of the initial
response from Robert Klein<\/b>, chairman of the California stem
cell agency until July 2011, to questions from the California Stem Cell Report <\/b>(CSCR)
concerning his $21,630 donation to the agency. The questions posed by
CSCR on precede the response by Klein. Here is a link to a story <\/a>on
the matter.<\/p>


<\/b><\/div>
CSCR to Klein:<\/div>

“Why did you give the agency the
money?
“Did you place on conditions on its
use?
“Did anyone connected with the agency
indicate in advance  that your donation would be desired? If so
who? Who did you deal with primarily on the donation -- Trounson,
Thomas or...?
“The donation came one month after
grant reviewers rejected StemCells Inc.'s Alzheimer's application. Do
you think it was appropriate to make the donation and then ask the
board twice to override its reviewers?
“Do you think the donation and
subsequent action on StemCells, Inc.'s Alzheimer's application will
negatively color the perception of future efforts by CIRM at private
fundraising?”<\/p><\/blockquote>

Klein's response:<\/div>
<\/div>
“In April or May of 2012 I committed
approximately $20,000 as a contribution to CIRM to cover the travel
expenses of staff to the International Stem Cell Society
meeting in Japan. My commitment to ensure scientific staff can
participate in international meetings dates back many years. In 2011
I wrote the following explanation of its importance in obtaining the
knowledge to accelerate the drive of scientific research to reach
patients with chronic disease.<\/div>
            Leverage
Leading Edge Science<\/div>
           
“Travel by CIRM staff members and leadership permits CIRM to stay
in contact with, and understand, the leading edge advances of
scientists all over the world, and to leverage those advances by
creating a platform for collaborations between these leading
scientists and their peers in California. Currently, CIRM has
collaboration agreements with 15 foreign governments pursuant to
which these governments have pledged $134,380,000 in commitments to
fund the work of their scientists on join teams with California
scientists to develop therapy candidates and to advance therapies to
human trials. Although a significant amount of this commitment is
currently pending scientific peer review and not all of it will be
awarded as part of a successful application, every dollar in
funding by a foreign government magnifies the scientific impact of
California’s taxpayer dollars. If just $40 million is awarded each
year over ten years, it would provide California with $400 million of
scientific leverage.<\/div>